Skip to the page

Data / Form D filings / ProteoWise Inc.

ProteoWise Inc.: Form D filings

ProteoWise Inc., a biotechnology company in New Haven, CT, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on December 13, 2024, reports $2.3 million sold of a $10 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
85 Willow Street, New Haven, CT, 06511
Phone
(203) 430-4187
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1807738

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 13, 2024New notice$10,000,000$2,306,020$7,693,9806Dec 6, 2024sec.gov
Apr 13, 2021New notice$2,653,558$2,653,5585Mar 31, 2021sec.gov
Mar 27, 2020New notice$6,295,940$6,295,94015Mar 23, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Daniel WagnerDirector
Benjamin D. CombDirector
Erik GuntherExecutive Officer, Director
David D. SmollerDirector

Other biotechnology companies in Connecticut that filed recently

Every Form D from the week of Dec 9, 2024 · All recent filings in Connecticut · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ProteoWise Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.